Abdominal And Pelvis Pain

Vaginal Moisturizer, Estradiol Tablet No Better Than Placebo

Vaginal Moisturizer, Estradiol Tablet No Better Than Placebo

Reduction of vulvovaginal symptoms in postmenopausal women similar in all three groups.

Efficacy of Moisturizer, Estradiol Tablets Examined in Treating Vulvovaginal Symptoms

Efficacy of Moisturizer, Estradiol Tablets Examined in Treating Vulvovaginal Symptoms

Similar reductions were seen for most bothersome symptom severity for all treatment groups over 12 weeks (estradiol, −1.4; moisturizer, −1.2; and placebo, −1.3).

Epidural Analgesia May Reduce Short-Term Mortality in Acute Pancreatitis

Epidural Analgesia May Reduce Short-Term Mortality in Acute Pancreatitis

By

Use of epidural analgesia in patients with critically acute pancreatitis may reduce the 30-day mortality rates compared with the absence of a pain management strategy.

Lateral Cutaneous Nerve Entrapment Syndrome: Newly Described Cause of Flank Pain

Lateral Cutaneous Nerve Entrapment Syndrome: Newly Described Cause of Flank Pain

By

Lateral Cutaneous Nerve Entrapment Syndrome, a newly defined syndrome characterized by flank tenderness, may successfully be treated with lidocaine injections and alternative treatments.

Trigger Point Injection Effective for Pelvic Floor Spasm in Men

Trigger Point Injection Effective for Pelvic Floor Spasm in Men

By

Trigger point injection as an adjunct to physical therapy is well tolerated and improves symptoms of pelvic floor muscle spasm in approximately 50% of patients with chronic prostatitis/chronic pelvic pain syndrome.

Cardiometabolic and Mortality Risks in Chronic Inflammatory Disorders

Cardiometabolic and Mortality Risks in Chronic Inflammatory Disorders

Certain inflammatory disorders may increase the risk for cardiometabolic events and all-cause mortality.

Caudal Block May Increase Intracranial Pressure in Children

Caudal Block May Increase Intracranial Pressure in Children

By

Caudal block for postoperative analgesia in pediatric populations may result in an increase in intracranial pressure when performed with a high volume of local anesthetic.

Remicade Biosimilar FDA-Approved

Remicade Biosimilar FDA-Approved

By

The FDA has approved Renflexis, the second approved biosimilar to Remicade.

Sign Up for Free e-Newsletters